Abbott to acquire Solvay
Monday, 28 September 2009
Rosalind Donald
US pharmaceuticals company Abbott is to acquire Belgium-based Solvay’s pharmaceuticals business for €4.5 billion, the company announced today.
PREMIUM Subscription required to view this article
This content can only be accessed by PREMIUM GCR subscribers.
A premium subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current and archived print & online content.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top